Open Access

Efficacy of increasing levels of exposure therapy in the treatment of maladaptive behaviors and anxiety

  • Authors:
    • Fatih Bal
  • View Affiliations

  • Published online on: October 3, 2023     https://doi.org/10.3892/mi.2023.115
  • Article Number: 55
  • Copyright : © Bal . This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The present study examined the effectiveness of increasing levels of exposure therapy, which is applied for the treatment of maladaptive behaviors and anxiety. A total of 16 sessions were applied to the study group in the experimental group three times a week for 10 weeks. Patients aged ≥18 years whom the referring clinician evaluated as meeting the criteria for the Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM‑V‑TR) Generalized Anxiety Disorder were included in the study. For the control group, demographic characteristics and Spielberger's State‑Trait Anxiety Inventory were applied in the first session, followed by Spielberger's State‑Trait Anxiety Inventory as a post‑test and follow‑up. Electroencephalography (EEG) recordings of the study group were obtained at the cortical level. Electrodes for EEG measurements were recorded using the International 10/20 Electrode Placement System. EEG data were obtained using the EEG Analysis Program software. Following the data collection phase, all data were entered into cells based on items using SPSS 25 software. When the findings obtained in the study were examined, it was determined that the increasing levels of exposure and behavioral therapy applied for maladaptive anxiety decreased the anxiety levels compared to those before therapy. This finding can be interpreted as that the cortical function‑oriented application method for anxiety effectively reduced the anxiety levels of the study group. However, EEG asymmetry revealed a change in the data before and after the application. These findings demonstrate that the application affects the EEG asymmetry changes at the cortical level.

Introduction

The expansion of the prefrontal cortex (PFC) in the human brain is considered to be responsible for the subjective experience of anxiety and the ability to regulate anxiety-related responses (1,2). While these abilities are advantageous for adapting to the environment, they also contribute to developing anxiety disorders (3). The PFC gathers information from various cortical and subcortical structures to plan adaptation actions. Understanding the function of the PFC has been aided by organizing principles that describe function gradients across the PFC, such as the configuration of the lateral PFC (LPFC) along the rostral/caudal axis based on the level of cognitive control (4). Research using neuroimaging and lesion analysis has suggested that rostral areas of the LPFC are involved in higher levels of cognitive control, processing more abstract representations (5).

The hippocampus, known for its role in memory formation, is also crucial in regulating emotions during fear conditioning (6). Unlike the amygdala, which processes cues anticipating a threat, the dorsal hippocampus provides contextual information about the specific threat cue through interactions with the amygdala and ventromedial PFC (7). The dorsal hippocampus encodes contextual information about the threat or cues learned when presented with a stimulus, allowing the organism to differentiate between threat and safety cues, and to evaluate the threat level associated with the stimulus (8,9). This ability to distinguish between threatening and safe features may be essential for automatic cognitive appraisal and reappraisal, contributing to emotion regulation. In animal studies, mice exposed to a tone predicting a shock learn to fear both the tone and the context in which the tone-shock pairs occur (10). Understanding the involvement of the hippocampus in emotional regulation can provide insight into the mechanisms through which emotions are processed and controlled.

Understanding the role of the PFC in anxiety disorders has been challenging due to the complex nature of neural processes associated with anxiety. The PFC is responsible for assessing the likelihood of a threat in the environment by gathering information from different brain regions (11). Distorted threat estimations can create a cycle of overreactions to perceived dangers, leading to anxiety and avoidance behaviors. The frontal lobe, specifically the PFC, has significantly evolved in primates, and abnormalities in prefrontal function have been linked to anxiety disorders and their symptoms (2). Therefore, the present study aimed to determine the effectiveness of increasing levels of exposure therapy, in reducing anxiety levels and combating maladaptive behaviors. Participants were first assessed according to Spielberger's State-Trait Anxiety Inventory and were included in the study according to whether they were anxious (score >17). Participants were randomly divided into the experimental and control groups, with a total of 30 participants.

Subjects and methods

Study design and ethics approval

The author initiated the data collection process after obtaining permission from the Ethics Committee of Sakarya University (registration no. 22.11.1122); written informed consent was obtained from all subjects. Subjects were under no obligation to participate in the study and were assured of the confidentiality of all information.

The present study was an experimental research study based on cause-and-effect relationships, using a pre-test and post-test control group design. Experimental studies examine the change caused by one or more dependent variables on an independent variable, providing accurate results using comparable methods. However, the present study was designed as a quasi-experimental model. The pre-test and post-test control group design is commonly employed in comparison studies conducted using experimental models. The present study specifically employed the pre-test post-test control group design (https://quantifyinghealth.com).

Within the scope of the research, two groups, one experimental and one control, were formed. Prior to the application, all participants in the experimental and control groups were tested for their anxiety levels. In order to strengthen the internal validity of the study, a pre-test comparison was made between the experimental and control groups. In the present study, the therapeutic application was applied to the participants in the experimental group for a total 36 sessions, three times a week for 10 weeks. No intervention was applied to the participants in the control group.

Participants

The study group comprised 60 individuals with anxiety disorders who applied to a private health clinic in Istanbul, Turkey. The selection of the working group and the flow chart are presented in Fig. 1.

The inclusion and exclusion criteria for the study were as follows: Participants were recruited from the clinical population and were reviewed separately by the referring psychiatrist. However, patients who ≥18 years of age and judged by the referring clinician to meet the criteria for Generalized Anxiety Disorder in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-V-TR) (12) were included. Participants were excluded if they expressed acute suicidal or homicidal ideation or showed acute psychotic symptoms. In addition, the exclusion criteria were as follows: The primary or secondary diagnosis met the criteria for obsessive-compulsive disorder, post-traumatic stress disorder, panic disorder, agoraphobia or acute stress disorder, the primary diagnosis was not an anxiety disorder, mental retardation, pervasive developmental disorder, psychosis, oppositional defiant disorder, conduct disorder or substance use was a co- or secondary diagnosis, the presence of a chronic disorder of organic origin and a recent trauma with ongoing forensic process.

Prior to commencing the research, all necessary units of the private health institution were informed about the research and the process, and the necessary permissions were obtained. All persons, units and institutions participating in the process were informed, and their application and research permissions were obtained.

Study procedure

At this stage, the participants in the study group were informed about the increasing levels of exposure therapy and cognitive behavioral therapy.

Sessions

After meeting with the client, a detailed conversation about anxiety, the treatment process for the client, and short and long-term treatment processes were determined. A form was prepared by discussing anxiety-related issues with each client and creating a list. Brain-based explanations for anxiety were given to each client. Short psychoeducational presentations were made for questions, such as how the brain works and what it needs. After the presentations, a form was created that included a list of clients who would participate in the exposure therapy and cognitive behavioral therapy. The goals selected from the list were divided into achievable tasks to gradually relieve the clients' anxiety. Behavioral changes were made by changing each client's behaviors towards different goals in this way and dividing them into small, easy practices. Clients were exposed to situations that aroused the sensation that they had difficulty in doing with increasing frequency, and the brain was reprogrammed. Any tasks that the clients could not carry out during the session were given to them as a home assignment. Unfulfilled home assignments were requested again, and support was provided for carrying out the home assignments. In this manner, the clients were provided with their comfort zones with measured and frequent steps, and the control of their home assignments was ensured. It was explained to the clients that moderate and reasonable anxiety strengthens memory. Thus, increasing levels of adrenaline in the brain play a role in encoding and reinforcing the implicit memory of the amygdala. This information enabled the clients to perform their home assignments meticulously. At the end of the application, the clients were informed that the research results would be shared and were thanked for their participation.

Assessment measurements

Anxiety levels for the experimental group were measured using Spielberger's State-Trait Anxiety Inventory (pre-test and post-test) immediately before and after using the therapeutic method. After applying this therapeutic method, the anxiety levels were measured again. The demographic characteristics of the participants and Spielberger's State-Trait Anxiety Inventory were filled in the first session for the control group; the Spielberger's State-Trait Anxiety Inventory was then completed again. The measurement tools used are described below.

Personal information form

This form included eight questions about sex, economic status, employment status, educational status and personal health.

Spielberger's State-Trait Anxiety Inventory

The scale measures normal and abnormal traits and state anxiety levels of individuals (3). There are a total of 40 short statements on the scale. The first 20 items measure the level of anxiety related to the situation, and each item is graded as ‘Not at all’ (1 point), ‘Somewhat’ (2 points), ‘Very’ (3 points) and ‘Totally’ (4 points). A number of items were reverse scored (items 1, 2, 5, 8, 10, 11, 15, 16, 19 and 20). State anxiety scores are obtained by adding the constant v0, the constant value of the state anxiety scale, to the value obtained by subtracting the total score of the reverse-coded items from the total score of the directly coded items. Items 21 to 40 of the scale measure the trait anxiety level of the individual, and each statement is scored as ‘Not at all’ (1 point), ‘A little’ (2 points), ‘Very’ (3 points) and ‘Totally’ (4 points). In this section, seven items are reverse-coded (articles 21, 26, 27, 33, 36 and 39 contain these items). The trait anxiety level of the individual is obtained by subtracting the total score of the reverse-coded items from the total score of the directly coded items and adding 35, which is the constant value of the trait anxiety scale. It states that 0-19 points obtained from the scale do not indicate anxiety, 20-39 points indicate mild anxiety, 40-59 points indicate moderate anxiety, and 60-79 points indicate severe anxiety; individuals with a score ≥60 required professional assistance (4).

Electroencephalography (EEG) measurements

Electrodes for EEG measurements were recorded using the International 10/20 Electrode Placement System. EEG data were visually scored for artifacts from blinking, eye movements and other motor movements when amplitudes exceeded ±50 V using the EEG Analysis Program software (WinEEG 256 EEG channels for QEEG/ERP processing and analysis) All artifact-free EEG data were analyzed using a 1-second-wide discrete Fourier transform (DFT). Power (square microvolts) was derived from the DFT output in three alpha frequency bands (alpha-I: 8-10 Hz; alpha-II: 10-13 Hz; full alpha: 8-13 Hz).

Statistical analyses

After the data collection phase was over, all data were entered into the cells on an item basis using the Statistical Program for Social Sciences 25 00 package program (IBM Corp.), and the total scores obtained from the scales were obtained.

The data obtained from the personal information form were analyzed using the descriptive analysis method, and the frequency and percentage distributions of the sociodemographic information of the study group were obtained. It was examined whether the data obtained exhibited a significant difference before and after the therapeutic application in the experimental and control groups. The data collected in the experimental and control groups were analyzed using descriptive and inferential statistical tests, such as an independent t-test (to compare the average depression level in the two groups) and a paired t-test (to compare the average depression level) using the SPSS-25 program to determine the anxiety level before and after the intervention. Moreover, the Chi-squared test was used to investigate the demographic characteristics of the study participants. Participants' Spielberger's Trait-State Anxiety Inventory, pretest, posttest, and follow-up test scores were analyzed by ANOVA and ANCOVA and multiple comparisons were analyzed using Tukey's HSD test. Finally, reliability analyses were conducted for the reliability of the scale used in the study. The results were evaluated at 95% confidence intervals. A value of P<0.05 was considered to indicate a statistically significant difference.

Results

Demographic characteristics of the study participants

All the demographic characteristics of the study participants are presented in Table I. The Chi-squared test was used to analyze demographic variables to determine whether the participants in the study were equally distributed in the experimental and control groups. Considering the sex variable of the experimental group in the study, the number of males was 46.7% (n=7) and that of females was 53.3% (n=8). The sex variable in the control group was considered; the number of males was 53.3.7% (n=8) and that of females was 46.7% (n=7). Considering the age variable of the experimental group, the number of participants between the ages of 18-25 years was 40.0% (n=6), that between 26-45 years was 20.0% (n=3), and the number of participants ≥46 years of age was 40.0% (n=6). Considering the age variable of the control group, the number of participants between the ages of 18-25 years was 40.0% (n=6) and the number of participants between the ages of 26-45 years was 20.0% (n=3). The number of participants over the age of 46 was 40% (n=6). Considering the educational variable of the experimental group, the number of primary school graduates was 40.0% (n=6), the number of secondary school graduates was 20.0% (n=3), the number of high school graduates was 13.3% (n=3), and that of university graduates was 26.7% (n=4). When the education variable of the control group was considered, the number of primary school graduates was 40.0% (n=6), the number of secondary school graduates was 20.0% (n=3), the number of high school graduates was 13% (n=3), and the number of university graduates was 26.7% (n=4). Considering the drug use variable in the experimental group, the number of participants using drugs was 40.0% (n=6), and the number of participants not using drugs was 60.0% (n=9). The number of participants using drugs (anti-depressants, benzodiazepine or others) was 53.3% (n=9) when looking at the variable of drug use in the control group. =8), and the number of participants who did not use drugs was 46.7% (n=9). Considering the marital status variable of the experimental group, the number of single participants was 46.7% (n=7), and the number of married participants was 53.3% (n=8). When the marital status variable of the control group was examined, the number of single participants was 40.0% (n=6), and the number of married participants was 60.0% (n=9) (Table I). As shown by these demographic variables, there were no statistically significant differences in demographic characteristics such as sex, education level, age, and drug use between the two groups and the characteristics were homogeneous (P>0.05).

Table I

Descriptive analysis comparison of the sociodemographic characteristics of the participants in the experimental and control groups.

Table I

Descriptive analysis comparison of the sociodemographic characteristics of the participants in the experimental and control groups.

 Analyses
VariableExperimental group, n (%)Control group, n (%)χ² valuedfP-value
Sex     
     Male7 (46.7)8 (53.3)0.6710.796
     Female8 (53.3)7 (46.7)   
     Total15 (100.0)15 (100.0)   
Age, years     
     18-256 (40,0)6 (40.0)1.20020.549
     26-453 (20,0)3 (20.0)   
     ≥466 (40,0)6 (40.0)   
     Total15 (100.0)15 (100.0)   
Level of education     
     Primary school6 (40.0)6 (40.0)2.30030.506
     Secondary school3 (20.0)3 (20.0)   
     High school2 (13.3)2 (13.3)   
     University4 (26.7)4 (26.7)   
     Total15 (100.0)15 (100.0)0.06710.736
Drug use     
     Yes6 (40,0)8 (53.3)   
     No9 (60,0)7 (46.7)   
     Total15 (100.0)15 (100.0)   
Marital status     
     Single7 (46.,7)6 (40.0)0.60010.439
     Married8 (53.3)9 (60.0)   
     Total15 (100.0)15 (100.0)   
Pre-test, post-test and follow-up test scores

As shown in Table II, in the experimental group, there was a significant difference between the participants' Spielberger's State-Trait Anxiety Inventory pre-test, post-test and follow-up test scores (Wilk's λ, 800=F (1.14)=29.122, P<0.001 ɳ2=0.530) and the effect size was calculated to be high. The post-test mean score (x̄=4.6667) and follow-up test mean score (x̄=4.4667) were lower than the pre-test mean score(x̄=8.0667) in Table III. On the other hand, in the control group the difference between the post-test and follow-up test scores was not significant. This finding shows that the participants' anxiety levels significantly decreased after the application and in the measurements made after the application, and the results did not change in the follow-up measurements made afterward. This finding shows that the effect of the application made in the research continues. The descriptive analysis results of the pre-test, post-test and follow-up test scores of the experimental and control groups are presented in Table III.

Table II

Results of repeated measures ANOVA of the pre-test, post-test and follow-up test scores of the study participants of the experimental group.

Table II

Results of repeated measures ANOVA of the pre-test, post-test and follow-up test scores of the study participants of the experimental group.

SourceSum of squaress.dMean squaresF valueP-valueEffect sizeDifference
Intercept56.711282.02529.1220.0010.5302>1, 3>1 3=2
Measurement67.489233.744    
Error64.889561.159    
Total189.08986     

[i] 1, Pre-test; 2, post-test; 3, follow-up test.

Table III

Results of descriptive analysis of the pre-test, post-test and follow-up test scores of the experimental and control groups.

Table III

Results of descriptive analysis of the pre-test, post-test and follow-up test scores of the experimental and control groups.

 Experimental groupControl group
Dependent variablePre-testPost-testFollow-upPre-testPost-testFollow-up
SSDKEMeanSdMeanSSMeanSdMeanSSMeanSdMeanSS
 8.06671.533754.66671.588654.46671.846498.06670.457747.73330.258207.86670.35187

[i] The Wilks' lambda value was 800 for the experimental group and 800 for the control group. The F value for the experimental group was 29.122. and the F value for the control was 1.625. P-values: 0.001 for the experimental group and 0.234 for the control group. SSDKE, Spielberger's State-Trait Anxiety Inventory.

As shown in Fig. 2, the pre-test Trait-State Anxiety mean score of the experimental group was 8.0667, the post-test mean score was 4.6667, and the follow-up mean score was 4.4667. The pre-test Trait-State Anxiety mean score of the control group was 8.0667, the post-test mean score was 7.733, and the follow-up mean score was 7.706. This finding indicates that the participants' anxiety levels markedly decreased after the application and in the measurements made after the application, and the results did not change in the follow-up measurements made afterwards. This finding indicates that the effect of the therapeutic application made in the research continues. On the other hand, it can be seen that there is no change in the control group. As shown in Fig. 2, it is clear that the change is due to the therapeutic application.

In addition, preliminary checks were made to confirm that the variances were not violated, reliable measurement of normality, linearity, homogeneity of variances, and homogeneity of regression trends. According to the results of ANCOVA, no significant difference was found between the post-test mean scores adjusted for Spielberger's State-Trait Anxiety Inventory according to sex (P>0.05) (Table IV). In other words, the results indicate that females and males do not react differently to the therapeutic approach used in the study.

Table IV

Results of ANCOVA for Spielberger's State-Trait Anxiety Inventory post-test scores according to sex.

Table IV

Results of ANCOVA for Spielberger's State-Trait Anxiety Inventory post-test scores according to sex.

Dependent variable: Post-test
Source of varianceSum of squaresdfMean squaresF valueP-valueEffect size
Corrected model10.05733,3521.4590.2790.285
Sex1.93611,936   
Pre-test1.02811,028   
re-test of sex1.02811,028   
Error25.276112,298   
Total362.,00015    
Corrected total35.33314    

[i] The analysis was performed on the experimental groups. R2=0.285 (adjusted R2=0.090).

EEG asymmetry changes at the cortical level

As shown in Fig. 3, in the pre-test, in the first measurement, the pre-test alpha frequency of the right frontal lobe was 5 Hz and that of the left frontal lobe was 2 Hz; in the second measurement, the alpha frequency of the right frontal lobe was 6 Hz and that of the left frontal lobe was 2 Hz; in the third measurement, the alpha frequency of the right frontal lobe was 6 Hz and that of the left frontal lobe was 2 Hz; in the fourth measurement, the alpha frequency of the right frontal lobe was 7 Hz and that of the left frontal lobe was 2 Hz. In the post-test, in the fifth measurement, the alpha frequency of the right frontal lobe was 5 Hz and that of the left frontal lobe was 5 Hz; in the sixth measurement, the alpha frequency of the right frontal lobe was 8 Hz and that of the left frontal lobe was 7 Hz; in the 7th measurement, the alpha frequency of the right frontal lobe was 6 Hz and that of the left frontal lobe was 6 Hz; in the 8th measurement, the alpha frequency of the right frontal lobe was 8 Hz and that of the left frontal lobe was 8 Hz. As can be seen by the graph in Fig. 3, a change was observed in the pre-test. There was no change in the post-test. These findings indicate that there was a marked interaction of the application according to the frontal region. Therefore, this indicates that the application affects EEG asymmetry changes at the cortical level.

The changes in the frontal and parietal lobe frequencies were examined. In the experimental group, the analysis was performed separately for the resting EEG asymmetry alpha right and left before and after the therapeutic application. It was determined that there was a significant interaction at 10-13 Hz for alpha right and left relative to the frontal region [t (14)=1.344, P<0.05]. This indicates a change in EEG asymmetry (please also see the aforementioned data; Fig. 3). In the experimental group, the analysis was performed separately for the resting EEG asymmetry alpha right and left before and after the application. It was determined that there was a significant interaction to the parietal region at 10-13 Hz for alpha right and left [(t (14)=3.111, P<0.05] (Table V) This indicates a change in EEG asymmetry asymmetry (please also see the aforementioned data; Fig. 3). These findings demonstrated that the therapeutic application affected the EEG asymmetry changes at the cortical level.

Table V

The changes in the right and left frontal and parietal lobe alpha frequencies (10-13 Hz) between the pre-test and post-test.

Table V

The changes in the right and left frontal and parietal lobe alpha frequencies (10-13 Hz) between the pre-test and post-test.

Group10-13 HzMeannStd. deviationdftP-value
Experimental groupFrontal lobePre-test right2.0000150.00000141.3440.05
  Post-test left6.0000150.81650   
 Parietal lobePre-test right2.5000150.29099143.1110.05
  Post-test left6.7500151.50000   

Discussion

In the present study, when the data obtained from the analyses were examined, the effectiveness of the gradually increasing levels of exposure therapy and cognitive behavioral therapy for maladaptive behavior and anxiety was examined. To date, to the best of our knowledge, there are no studies available in Turkey on the application of such methods, namely a brain-based psychological intervention program for anxiety. Therefore, the study is the first of its kind in Turkey. Herein, it was found that the methods used for maladaptive behavior and anxiety were effective and reduced the levels of anxiety in the study participants. This finding can be interpreted as an effective application method for anxiety.

According to the follow-up evaluations at the end of the therapy, it was stated by all clients that they benefited greatly from the therapeutic application and that their quality of life increased compared to that before the therapy. A previous study on cognitive behavioral therapy demonstrated that the participants experienced a significant shift in their resting forebrain activity from greater relative right to greater relative left after receiving treatment (13). That study also found that individuals with higher levels of left frontal brain activity before treatment had larger reductions in anxiety symptoms after treatment and lower levels of anxiety post-treatment (11). These associations were specifically related to the frontal alpha EEG asymmetry metric. These findings suggest that resting frontal EEG asymmetry may indicate symptom improvement and overall functioning in anxious patients who receive effective psychological treatment (11). The results of the present study are supported by other international research that has shown alterations in neural circuits related to anxiety disorders, such as exaggerated amygdala responses and impaired regulation by the PFC and hippocampus (14,15). Exposure to chronic stress can also affect the brain's fear circuitry; however, pharmacological and non-pharmacological interventions can help reverse this damage (16,17).

The frontal EEG asymmetry-emotion model suggests that individuals with greater right frontal asymmetry exhibit higher anxiety symptoms (13). However, other researchers have found that the association between EEG asymmetry, withdrawal behavior and negative effects is more complex (18). Anxiety disorders are characterized by difficulties regulating emotional responses to perceived threats (19). This may be due to increased activity in the amygdala and other limbic/subcortical regions, decreased activity in the PFC and hippocampus, or a failure of top-down processes to regulate the ventral nervous system (20). Individuals with anxiety disorders often display a heightened sensitivity to threats or negative information in their environment, selectively attending to and experiencing increased amygdala activity in response to threats. There is evidence to indicate an association between anxiety disorders and heightened reactivity to threats and negative stimuli (21).

The hippocampus has provided valuable insight into understanding the impact of stress on the brain. Research has expanded to include interconnected regions, such as the amygdala and PFC (22). In rodents, chronic stress has been shown to lead to the degeneration of the PFC, specifically dendritic and spine loss in pyramidal cells, associated with impaired working memory (23). Notably, chronic stress has differential effects on different brain circuits. While dendritic growth increases in the amygdala, leading to an imbalance between the amygdala and prefrontal cortex function, the PFC neurons that form connections with other cortical areas undergo dendritic loss (23). However, neurons in the orbital prefrontal cortex and those that activate the amygdala do not atrophy during chronic stress. These findings highlight the complex effects of stress on brain structures and the interconnectedness of different brain regions (24).

A previous study discussed the association between reduced gray matter volume in the PFC and exposure to adverse events in humans. It also highlighted the impact of chronic stress on the functional connectivity and regulation of the PFC by the amygdala (23). Another study followed depressed adults over a period of 3 years and found that those who went into remission had less volume reduction in certain brain regions, such as the hippocampus and various regions of the PFC, compared to those who did not go into remission (25). The present study points out that internal and external factors were not fully controlled in the study and mentions that there was no control group for EEG data, which limits the certainty of attributing the changes observed to the treatment alone. The text emphasizes the need for further research to establish causality in the relationship between changes in EEG asymmetry and brain regions. It acknowledges that the data obtained from scales may suggest a relationship but recognizes these limitations.

In line with the results obtained from the present study, further studies need to be conducted in Turkey, to further examine the effectiveness of increasing levels of exposure and behavioral therapy for maladaptive behavior and anxiety. It is also recommended that this therapy be used in clinics as a psychotherapy method and presented as behavioral homework. It is also recommended that brain-based methods be added as an additional protocol to all psychotherapy methods, applied and recommended for other psychological problems other than anxiety. It is recommended that the findings in the present study should be confirmed by supported other studies and repeated in future studies with different samples or study groups.

Acknowledgements

Not applicable.

Funding

Funding: No funding was received.

Availability of data and materials

The datasets used and analyzed during the current study are available from the corresponding author upon reasonable request.

Author's contributions

The author FB was responsible for the study design, the analyses and the literature search, and the writing of the study. The author has read and approved the final manuscript.

Ethics approval and consent to participate

All procedures performed in studies involving human participants were under the ethical standards of the institutional or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. The author initiated the data collection process after obtaining permission from the Ethics Committee of Sakarya University (registration no. 22.11.1122); written informed consent was obtained from all subjects. Subjects were under no obligation to participate in the study and were assured of the confidentiality of all information.

Patient consent for publication

Not applicable.

Competing interests

The author declares that he has no competing interests.

References

1 

Armstrong E, Zilles K, Curtis M and Schleicher A: Cortical folding, the lunate sulcus and the evolution of the human brain. J Hum Evolution. 20:341–348. 1991.

2 

Coan JA and Allen JJB: Frontal EEG asymmetry and the behavioral activation and inhibition systems. Psychophysiology. 40:106–114. 2003.PubMed/NCBI View Article : Google Scholar

3 

Kenwood MM, Kalin NH and Barbas H: The prefrontal cortex, pathological anxiety, and anxiety disorders. Neuropsychopharmacology. 47:260–275. 2022.PubMed/NCBI View Article : Google Scholar

4 

Miller EK and Cohen JD: An integrative theory of prefrontal cortex function. Ann Rev Neurosci. 24:167–202. 2001.PubMed/NCBI View Article : Google Scholar

5 

Badre D and D'Esposito M: Functional magnetic resonance imaging evidence for a hierarchical organization of the prefrontal cortex. J Cogn Neurosci. 19:2082–2099. 2007.PubMed/NCBI View Article : Google Scholar

6 

Tanji J and Hoshi E: Behavioral planning in the prefrontal cortex. Curr Opin Neurobiol. 11:164–170. 2001.PubMed/NCBI View Article : Google Scholar

7 

Thompson RF and Kim JJ: Memory systems in the brain and localization of a memory. Proc Natl Acad Sci USA. 93:13438–13444. 1996.PubMed/NCBI View Article : Google Scholar

8 

Fell J, Klaver P, Elfadil H, Schaller C, Elger CE and Fernández G: Rhinal-hippocampal theta coherence during declarative memory formation: Interaction with gamma synchronization? Eur J Neurosci. 17:1082–1088. 2003.PubMed/NCBI View Article : Google Scholar

9 

Maren S, Phan KL and Liberzon I: The contextual brain: Implications for fear conditioning, extinction, and psychopathology. Nat Rev Neurosci. 14:417–428. 2013.PubMed/NCBI View Article : Google Scholar

10 

Curzon P, Rustay NR and Browman KE: Cued and Contextual Fear Conditioning for Rodents. In: Methods of Behavior Analysis in Neuroscience. 2nd edition. CRC Press/Taylor & Francis, Boca Raton (FL), 2009.

11 

Britton JC, Lissek S, Grillon C, Norcross MA and Pine DS: Development of anxiety: The role of threat appraisal and fear learning. Depress Anxiety. 28:5–17. 2011.PubMed/NCBI View Article : Google Scholar

12 

American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. Fifth edition. Washington, DC, American Psychiatric Association, 2013. See more at: http://www.adhdinstitute.com/assessment diagnosis/diagnosis/dsm-5tm/#sthash.8YJw9SHo.dpuf.

13 

Moscovitch DA, Santesso DL, Miskovic V, McCabe RE, Antony MM and Schmidt LA: Frontal EEG asymmetry and symptom response to cognitive behavioral therapy in patients with social anxiety disorder. Biol Psychol. 87:379–385. 2011.PubMed/NCBI View Article : Google Scholar

14 

Herry C, Ferraguti F, Singewald N, Letzkus JJ, Ehrlich I and Lüthi A: Neuronal circuits of fear extinction. Eur J Neurosci. 31:599–612. 2010.PubMed/NCBI View Article : Google Scholar

15 

Kim MJ, Loucks RA, Palmer AL, Brown AC, Solomon KM, Marchante AN and Whalen PJ: The structural and functional connectivity of the amygdala: From normal emotion to pathological anxiety. Behav Brain Res. 223:403–410. 2011.PubMed/NCBI View Article : Google Scholar

16 

Jaggar M, Fanibunda SE, Ghosh S, Duman RS and Vaidya VA: The neurotrophic hypothesis of depression revisited: New insights and therapeutic implications in Neurobiology of depression. Academic Press, 2019.

17 

Mah L, Szabuniewicz C and Fiocco AJ: Can anxiety damage the brain? Curr Opin Psychiatry. 29:56–63. 2016.PubMed/NCBI View Article : Google Scholar

18 

Thayer JF, Friedman BH, Borkovec TD, Johnsen BH and Molina S: Phasic heart period reactions to cued threat and nonthreat stimuli in generalized anxiety disorder. Psychophysiology. 37:361–368. 2000.PubMed/NCBI

19 

Siever LJ: Neurobiology of aggression and violence. Am J Psychiatry. 165:429–442. 2008.PubMed/NCBI View Article : Google Scholar

20 

Streeter CC, Gerbarg PL, Saper RB, Ciraulo DA and Brown RP: Effects of yoga on the autonomic nervous system, gamma-aminobutyric acid, and allostasis in epilepsy, depression, and post-traumatic stress disorder. Med Hypotheses. 78:571–579. 2012.PubMed/NCBI View Article : Google Scholar

21 

McEwen BS, Nasca C and Gray JD: Stress effects on neuronal structure: Hippocampus, amygdala, and prefrontal cortex. Neuropsychopharmacology. 41:3–23. 2016.PubMed/NCBI View Article : Google Scholar

22 

Hains AB, Vu MAT, Maciejewski PK, van Dyck CH, Gottron M and Arnsten AF: Inhibition of protein kinase C signaling protects prefrontal cortex dendritic spines and cognition from the effects of chronic stress. Proc Natl Acad Sci USA. 106:17957–17962. 2009.PubMed/NCBI View Article : Google Scholar

23 

Arnsten AF: Stress signaling pathways impair prefrontal cortex structure and function. Nat Rev Neurosci. 10:410–422. 2009.PubMed/NCBI View Article : Google Scholar

24 

Sarter M, Givens B and Bruno JP: The cognitive neuroscience of sustained attention: Where top-down meets bottom-up. Brain Res Rev. 35:146–160. 2001.PubMed/NCBI View Article : Google Scholar

25 

Frodl TS, Koutsouleris N, Bottlender R, Born C, Jäger M, Scupin I, Reiser M, Möller HJ and Meisenzahl EM: Depression-related variation in brain morphology over 3 years: Effects of stress? Arch Gen Psychiatry. 65:1156–1165. 2008.PubMed/NCBI View Article : Google Scholar

Related Articles

Journal Cover

September-October 2023
Volume 3 Issue 5

Print ISSN: 2754-3242
Online ISSN:2754-1304

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Bal F: Efficacy of increasing levels of exposure therapy in the treatment of maladaptive behaviors and anxiety. Med Int 3: 55, 2023.
APA
Bal, F. (2023). Efficacy of increasing levels of exposure therapy in the treatment of maladaptive behaviors and anxiety. Medicine International, 3, 55. https://doi.org/10.3892/mi.2023.115
MLA
Bal, F."Efficacy of increasing levels of exposure therapy in the treatment of maladaptive behaviors and anxiety". Medicine International 3.5 (2023): 55.
Chicago
Bal, F."Efficacy of increasing levels of exposure therapy in the treatment of maladaptive behaviors and anxiety". Medicine International 3, no. 5 (2023): 55. https://doi.org/10.3892/mi.2023.115